Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02141828 |
Title | A Phase 1 Dose Escalation and Expanded Cohort Study of EPZ-5676 in the Treatment of Pediatric Patients With Relapsed/Refractory Leukemias Bearing a Rearrangement of the MLL Gene |
Recruitment | Completed |
Gender | both |
Phase | Phase I |
Variant Requirements | Yes |
Sponsors | Epizyme, Inc. |
Indications | |
Therapies | |
Age Groups: | child |
Covered Countries | USA | CAN |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Childrens Hospital Los Angeles | Los Angeles | California | 90027 | United States | Details | |
University of California San Francisco Medical Center-Parnassus | San Francisco | California | 94143 | United States | Details | |
Children's Hospital Colorado | Aurora | Colorado | 80045 | United States | Details | |
Emory Children's Healthcare of Atlanta | Atlanta | Georgia | 30322 | United States | Details | |
Johns Hopkins University | Baltimore | Maryland | 21287 | United States | Details | |
Dana Farber Cancer Institute | Boston | Massachusetts | 02215 | United States | Details | |
Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | United States | Details | |
The Hospital for Sick Kids | Toronto | Ontario | Canada | Details |